SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Clouseau who wrote (1020)2/14/2001 3:11:57 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 1029
 
Dave:
I do not own ICN, but just posted this as a courtesy. Therefor, I can not answer your Q about the IPO.The basic current ratio seems healthy, why the secondary?

I have just started looking at ICN as a possible buy. Certainly, the price is nearing 52 wk lows and the P/E is low at 17. Even a yield(1.1%)! Wow for a biotech.

SP Reports has a AVIOD rating on it.

Jim